DexCom, Inc. - Common Stock (DXCM) stock analysis
DXCM · DexCom, Inc. - Common Stock
Latest recorded price: USD 81.61
Model-estimated fair value: USD 48.98. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $81.61, DXCM trades 66.6% above the model's base-case value of $48.98. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $37.71 in the conservative case and $62.46 in the optimistic case, with a valuation confidence score of 93/100. Fiscal 2025 figures: revenue growth 17.0%, free cash flow margin 23.1%, ROIC 40.4%. The model does not flag any risk signals for this company.
Similar companies in Healthcare
- Enovis Corporation (ENOV)
- Establishment Labs Holdings Inc. (ESTA)
- Edwards Lifesciences Corporation (EW)
- GE HealthCare Technologies Inc. - Common Stock (GEHC)
- Glaukos Corporation Common Stock (GKOS)
- Globus Medical, Inc. (GMED)
- Haemonetics Corporation (HAE)
- Integra LifeSciences Holdings Corporation - Common Stock (IART)